GWM Advisors LLC
- SEC CIK
- 0001633516
- Latest filing
- Aug 12, 2026
MACK holding history
Merrimack Pharmaceuticals Inc in every 13F filed by GWM Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MACK overviewAll 13F holders of MACKFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −1,406−100.0% | Sold out | Holders |
| Q1 2024 | 1,406 | $20.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,406 | $18.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,406 | $17.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,406 | $17.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,406 | $17.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,406 | $16 | <0.1% | +1,406 | New | Holders |